本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 一、本期业绩预计情况 1、业绩预告期间：2025年1月1日至2025年12月31日。 2、业绩预告情况：自愿性业绩预告 （1）以区间数进行业绩预告的 单位：万元 二、与会计师事务所沟通情况 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:000623 证券简称:吉林敖东 公告编号:2026-001 公司已就业绩预告有关事项与会计师事务所进行了预沟通，公司与会计师事务所在业绩预告方面不存在 分歧。本次业绩预告未经过注册会计师预审计。 三、业绩变动原因说明 报告期内，公司围绕市值管理，聚焦医药主业，持续提升经营质量，积极践行"专注于人、专精于药"的 企业价值观，实施"大品种群、多品种群"的销售拉动政策，坚持走"医药健康+金融资本"双轮驱动快速 发展的道路，按照年初制定的估值提升计划有序推进各项工作，业绩取得大幅增长主要原因是公司公允 价值变动收益及投资收益同比增加。 2025年，预计非经常性损益金额对净利润的影响金额约为19,568.93万元（2024年同期为-2,151.12万 元）。 四、风险提示 1 ...

Core Viewpoint - Jiufeng Energy (605090) aims to become the most valuable clean energy service provider, focusing on enhancing core competitiveness across its business segments and exploring new growth opportunities [1] Business Development - The company has established a business development structure consisting of clean energy, energy services, and specialty gases, referred to as "one main and two wings" [1] - Jiufeng Energy has maintained stable growth in operating performance since its listing [1] Shareholder Value - The company actively protects the interests of all shareholders through continuous cash dividends and share buybacks since its listing [1] - Efforts are being made to enhance the company's brand value in the capital market [1] Future Strategy - Jiufeng Energy plans to continue implementing its business development strategy and strengthen operational management to enhance intrinsic value [1] - The company will optimize its market value management and investor relations management in accordance with the "Guidelines for the Supervision of Listed Companies No. 10 - Market Value Management" [1]

Group 1 - The company emphasizes the importance of market capitalization management and is actively working to enhance its performance in the capital market [1] - Strategies employed by the company include improving operational performance, share buybacks, profit distribution, and investor relations management [1]

Core Viewpoint - Jilin Aodong (000623.SZ) expects a significant increase in net profit for the fiscal year 2025, projecting a range of 2.265 billion to 2.482 billion yuan, representing a growth of 46.00% to 60.00% compared to the previous year [1] Financial Performance - The net profit attributable to shareholders is projected to be between 2.265 billion and 2.482 billion yuan, with a year-on-year growth of 46.00% to 60.00% [1] - The net profit after deducting non-recurring gains and losses is expected to be between 2.069 billion and 2.287 billion yuan, reflecting a growth of 31.56% to 45.37% year-on-year [1] - The impact of non-recurring gains and losses on net profit is estimated to be approximately 195.6893 million yuan for 2025, compared to -21.5112 million yuan in the same period of 2024 [1] Strategic Focus - The company is focusing on value management and enhancing operational quality, adhering to its corporate values of "focusing on people and specializing in medicine" [1] - The implementation of a sales-driven policy centered on "large product groups and multiple product groups" is a key strategy for growth [1] - The company is pursuing a dual-driven development model of "pharmaceutical health + financial capital" to accelerate its growth [1]

证券日报网讯1月30日，中国中铁（601390）在互动平台回答投资者提问时表示，公司自上市以来一直 高度重视市值管理工作，通过不断完善公司治理、提升经营质量、充分开展资本运作、稳定分红、提高 信息披露和投资者关系管理水平等多种方式开展市值管理。未来，公司将继续致力提高经营质效，努力 加大分红频次，积极维护股价、回报股东。 ...

Core Viewpoint - Xuantai Pharmaceutical emphasizes the importance of market value management and aims for high-quality development to reward investors through improved performance [1] Group 1 - The company's stock price in the secondary market is influenced by various factors, including market conditions [1] - Xuantai Pharmaceutical is committed to enhancing operational management to achieve its development goals [1] - The company continuously focuses on high-quality growth to benefit its investors [1]

Core Viewpoint - The company emphasizes the importance of market value management and has established a "2025 Valuation Enhancement Plan" to focus on its core business and strengthen investor returns [1] Group 1: Company Strategy - The company is committed to enhancing its intrinsic value through focused operations and improved investor returns [1] - The company holds equity in Mingming Hen Mang, which is measured at fair value and its fluctuations are included in current profits and losses, supporting the company's long-term development [1] Group 2: Compliance and Operations - The company asserts that its operations are legal and compliant, with no significant risks that should have been disclosed but were not [1] - The company will continue to concentrate on its core business to deliver solid performance and return investor trust [1]

Group 1 - The company emphasizes the importance of market value management and has developed relevant management systems and work plans [1] - The company aims to actively maintain its market value by improving operational quality, standardizing corporate governance, enhancing information disclosure, and strengthening communication with investors [1]

Group 1: Business Development and Strategy - The company faced significant price reduction challenges in the automotive parts market due to intense competition, prompting a focus on internal management transformation and cost reduction strategies [2] - In 2025, the company implemented a cost control strategy that led to a substantial decrease in procurement expenses, resulting in a significant year-on-year increase in total profit and net profit attributable to shareholders [2] - The company plans to expand its business through mergers and acquisitions, targeting both automotive thermal management and other high-value automotive parts industries to enhance core competitiveness [3] Group 2: International Business Expansion - The company aims to strengthen its overseas business management and planning in 2026, with profitable operations already established in India, Thailand, Slovakia, and Morocco [4] - The Thai factory is experiencing rapid growth, and there are plans to build factories in ASEAN countries to tap into emerging markets [4] - In North America, the company expects significant improvements in performance due to better management practices and increased local production rates, addressing fluctuating tariff policies [5] Group 3: Energy Storage and Thermal Management - The energy storage thermal management business, initiated in 2021, faced challenges due to market conditions but is expected to recover significantly in 2025, particularly in the electric truck sector [6] - The company is considering entering the data center temperature control market to enhance its position in the water cooling market [6] Group 4: Market Value Management - The core of market value management is solid performance support and a clear future development outlook, with significant improvements in internal governance and business expansion since the acquisition by Changjiang Industrial Group [8] - The reduction of shareholding by major shareholders has alleviated market concerns, and the company plans to enhance market value management through diversified information disclosure and strengthened investor relations [8]

证券日报网讯1月30日，璞泰来（603659）在互动平台回答投资者提问时表示，公司一直非常重视市值 管理工作，致力于通过聚焦主业、改善经营、提升业绩等实际行动提升公司价值。 ...